PM

Professor Maskell

Mr Maskell has international experience in science and commerce, with a focus in research, academia, and entrepreneurship. Professor Maskell is the Vice-Chancellor of the University of Melbourne. Prior to this he was Senior Pro-Vice-Chancellor at the University of Cambridge in the United Kingdom and has also held roles at the University of Oxford, Imperial College London, and Wellcome Biotech. Professor Maskell has experience across the private sector, reflecting his passion for the commercialisation of research initiatives. He has co-founded several biotech companies, including Arrow Therapeutics, which was sold to biopharmaceutical company AstraZeneca, and Discuva, which was sold to Summit Therapeutics. He is Member of the Innovation and Development Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
29/10/2401,694N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
21/08/24
Issued
220$304.077$66,897Director remuneration
16/08/24
Buy
338$305.337$103,204Conversion of securities
16/08/24
Exercise
338$305.337$103,204Conversion of securities
16/02/24
Exercise
339$284.000$96,276Conversion of securities
16/02/24
Buy
339$284.000$96,276Conversion of securities